Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Datametrex AI Ltd V.DM

Alternate Symbol(s):  DTMXF

Datametrex AI Limited is a technology-focused company with exposure to artificial intelligence, healthcare, and mobile gaming. It is focused on collecting, analyzing and presenting structured and unstructured data using machine learning and artificial intelligence. The Company's products include AnalyticsGPT, Cyber Security, and Healthcare. AnalyticsGPT platform scans vast data streams from... see more

TSXV:DM - Post Discussion

Datametrex AI Ltd > Spin out
View:
Post by Mario79 on Aug 05, 2023 11:54am

Spin out

Does anyone want to share their views on how the spin out will work? One guess without any evidence is that DM buys VTAL. But if they do that they will need to purchase all their shares at 5 cents (maybe that's the exchange minimum but not sure). If that's the case it will be 120 million multiply by 5 cents which is 6 million doses minus the shares they own. But then if the buy VTAL and go be back the value of medical vertical to us then how would it work giving us shares in VTAL. Any comments on how this might play out? I guess we will need to vote on any potential spin out at the AGM and maybe that's the delay.
Comment by Pandora on Aug 05, 2023 12:26pm
VTAL is Justera which was ScreenPro which was a part of DM? Is this a case of all the way round the mulberry bush?
Comment by inviolablspirit on Aug 06, 2023 4:00am
Screenpro was not a spin out.  Dm was required by the exchange to run the Covid through another company which was screen pro.   And just for the record, Graph blockchain was not a spin out either.  I suspect graph was bought for their encryption technology.   Medicall will be DM's first spin which I think is a good decision by the company and for Medicall.  This is ...more  
Comment by inviolablspirit on Aug 06, 2023 4:05am
DM will not be buying VTAL.  It makes no sense to do so.  DM is seperating the Medical/health division of their company.  Although I believe DM may still hold some shares in the company.  
Comment by rollthedice10 on Aug 06, 2023 10:51am
DM owns a boatload of shares in both VTAL ( formerly Screenpro ) and Graph Blockchain. If these Companies do well, DM will will benefit. Spinning out Medicall as a stand alone pure play is likely good strategy. Shareholders of DM will receive shares in the new medical company which I think will do very well on it's own. Dm itself might hold some amount of shares in the new company as well, all ...more  
Comment by Pandora on Aug 06, 2023 2:34pm
From what I can see in the "ScreenPro" news releases on November 16, 2021 ScreenPro acquired Concierge Medical Services from Datametrex (the sole owner of Concierge) by issuing to Datametrex 36M shares of ScreenPro. A decent sized holding! However, on February 23, 2022, Screenpro announced a consolidation of shares, first at 1 for 10 and further amended and completed on the basis of 1 ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities